ESR1 and neoplasm: Overexpression of GRP78 is indicative of a more aggressive phenotype since it is overexpressed with higher frequency in high-grade estrogen-receptor-negative tumours than in low-grade estrogen-receptors-positive tumours [102] in line with the idea that UPR activation may play a protective role against apoptosis in tumour cells.